2-74003213-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001287491.2(TET3):c.360+47G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00696 in 1,547,692 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0046 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0072 ( 48 hom. )
Consequence
TET3
NM_001287491.2 intron
NM_001287491.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.281
Genes affected
TET3 (HGNC:28313): (tet methylcytosine dioxygenase 3) Enables methyl-CpG binding activity and zinc ion binding activity. Involved in histone H3-K4 trimethylation; positive regulation of transcription by RNA polymerase II; and protein O-linked glycosylation. Predicted to be located in cytoplasm and male pronucleus. Predicted to be active in nucleus. Biomarker of esophagus squamous cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 2-74003213-G-A is Benign according to our data. Variant chr2-74003213-G-A is described in ClinVar as [Benign]. Clinvar id is 1342286.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00459 (697/151998) while in subpopulation NFE AF= 0.00792 (538/67956). AF 95% confidence interval is 0.00736. There are 2 homozygotes in gnomad4. There are 309 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TET3 | NM_001287491.2 | c.360+47G>A | intron_variant | ENST00000409262.8 | NP_001274420.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TET3 | ENST00000409262.8 | c.360+47G>A | intron_variant | 1 | NM_001287491.2 | ENSP00000386869.3 | ||||
TET3 | ENST00000305799.8 | c.81+47G>A | intron_variant | 5 | ENSP00000307803.8 |
Frequencies
GnomAD3 genomes AF: 0.00459 AC: 697AN: 151880Hom.: 2 Cov.: 31
GnomAD3 genomes
AF:
AC:
697
AN:
151880
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00486 AC: 705AN: 145128Hom.: 4 AF XY: 0.00487 AC XY: 381AN XY: 78186
GnomAD3 exomes
AF:
AC:
705
AN:
145128
Hom.:
AF XY:
AC XY:
381
AN XY:
78186
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00722 AC: 10080AN: 1395694Hom.: 48 Cov.: 31 AF XY: 0.00715 AC XY: 4920AN XY: 688344
GnomAD4 exome
AF:
AC:
10080
AN:
1395694
Hom.:
Cov.:
31
AF XY:
AC XY:
4920
AN XY:
688344
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00459 AC: 697AN: 151998Hom.: 2 Cov.: 31 AF XY: 0.00416 AC XY: 309AN XY: 74330
GnomAD4 genome
AF:
AC:
697
AN:
151998
Hom.:
Cov.:
31
AF XY:
AC XY:
309
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Beck-Fahrner syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at